Hospitals & manufacturers clash over medical costs while patients pay the price for systemic pricing gaps.
India’s healthcare sector seeks a collaborative solution to medical overpricing amid rising tensions between hospitals & manufacturers.
The Indian healthcare sector currently faces a significant debate over rising medical costs and the need for transparent pricing. Consequently, hospitals and medical technology companies find themselves at a crossroads regarding the true cost of care. Recent investigations by the Maharashtra Food and Drug Administration highlighted massive gaps between procurement prices and retail costs.
Therefore, regulators now seek stricter price controls on essential hospital consumables and various medical devices. This scrutiny follows widespread social media complaints from patients regarding inflated bills and expensive medical supplies. However, industry stakeholders argue that a simple price cap might overlook complex operational realities within modern hospitals.
The Association of Healthcare Providers of India suggests that pricing reflects the entire healthcare delivery ecosystem. Specifically, Dr Girdhar Gyani believes hospitals must account for patient safety and clinical outcomes when pricing medicines. Furthermore, NATHEALTH claims hospitals act as more than just resellers for sophisticated medical technology.
Siddhartha Bhattacharya notes that hospitals manage clinical evaluations, sterile-chain integrity, and emergency inventory for every device. Consequently, these facilities assume significant responsibility for quality and compliance before a product reaches a patient. They argue for a framework that distinguishes between basic supplies and high-complexity medical technologies.
Meanwhile, medical device manufacturers propose an alternative to the ongoing pricing crisis. The Association of Indian Medical Devices Industry suggests rationalising trade markups within a specific band. Rajiv Nath believes that evidence-driven pilots should test these markups before implementing national policy changes.
Furthermore, manufacturers argue that hospital buyers often dictate the maximum retail prices to secure higher business margins. This practice reportedly forces ethical suppliers to comply with a skewed system to maintain market access. Therefore, the onus of fair pricing should shift toward a shared responsibility across the entire value chain.
Unresolved disputes between these sectors could cause long-term reputational damage to the national healthcare industry. Ultimately, policymakers must facilitate a collaborative approach to ensure affordable care without compromising medical innovation. A unified strategy remains essential to protect patients from the growing burden of medical inflation.
(Source: Express Healthcare)
Read more Healthcare News by clicking the 🔗 link.
